SEARCH

SEARCH BY CITATION

References

  • 1
    Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007;10(Suppl 2):S125S137.
  • 2
    US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research and US Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for Industry: patient reported outcome measures: use in medical product development to support labelling claims: draft guidance. Health Qual Life Outcomes 2006;4:79.
  • 3
    European Medicines Agency. Committee for medicinal products for human use (CHMP). Reflection paper on the regulatory guidance for the use of health-related quality of life (HROL) measures in the evaluation of medicinal products. European Medicines Agency website, 2005 (cited 2007 April). http://www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf.
  • 4
    Baiardini I, Braido F, Tarantini F, Porcu A, Bonini S, Bousquet J et al. ARIA suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN Review. Allergy 2008;63:660669.
  • 5
    Baiardini I, Braido F, Brandi S, Tarantini F, Bonini S, Bousquet J et al. The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA2LEN review. Allergy 2008; 63:10151030.
  • 6
    Baiardini I, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A et al. Recommendations for assessing Patient-Reported Outcomes and Health-Related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy 2010;65:290295.
  • 7
    Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19 June - 22 July 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948.
  • 8
    Guyatt GH, Oxman AD, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924926.
  • 9
    WHOQOL group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995;41:14031409.
  • 10
    The WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46:15691585.
  • 11
    Schipper H, Clinch J, Olweny CLM. Quality of life studies: definitions and conceptual issues. In: SpilkerB, editors. Quality of Life and Pharmacoeconomics in Cinical Trials. Philadelphia: Lippincot-Raven Press, 1990:1123.
  • 12
    Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardised version of the Asthma Quality of Life Questionnaire. Chest 1999;115:12651270.
  • 13
    Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of a standardised version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999;104:364369.
  • 14
    Baiardini I, Pasquali M, Giardini A, Specchia C, Passalaqua G, Venturi S et al. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003;58:289294.
  • 15
    Curtis JR, Patrick DL. The assessment of health status among patients with COPD. Eur Respir J 2003;41:3645.
  • 16
    De Vries J. Quality of life assessment. In: VingerhoetsAJJN, editor. Assessment in Behavioural Medicine. Hove, UK: Brunner-Routledge, 2001:353370.
  • 17
    Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey. Manual and Interpretation Guide. Boston: Health Institute, New England Medical Center, 1993.
  • 18
    Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham health profile: subjective health status and medical consultations. Sci Med 1981;15:221229.
  • 19
    Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost- Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
  • 20
    Bennet KJ, Torrance GW. Measuring health state preferences and utilities: rating scale, time trade-off and standard gamble techniques. In: SpilkerB, editor. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven, 1996:253265.
  • 21
    Preedy VR, Watson RR. Handbook of Disease Burdens and Quality of Life Measures. New York: Springer, 2009.
  • 22
    Hunt SM, McKenna S. A British adaptation of the general Well-being Index: a new tool for clinical research. British J Med Economics 1992;2:4960.
  • 23
    Baiardini I, Giardini A, Pasquali M, Dignetti P, Guerra L, Specchia C et al. Quality of life and patients’ satisfaction in chronic urticaria and respiratory allergy. Allergy 2003;58:621623.
  • 24
    Majani G, Baiardini I, Giardini A, Senna GE, Minale P, D’Ulisse S et al. Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 2001;56:313317.
  • 25
    Campbell JL, Kiebert GM, Partridge MR. Development of the satisfaction with inhaled asthma treatment questionnaire. Eur Respir J 2003;22:127134.
  • 26
    Haynes RB. Determinants of Compliance: The Disease and the Mechanics of Treatment. Baltimore MD: Johns Hopkins University Press, 1979.
  • 27
    Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol, 1993;72:68D74D.
  • 28
    Cohen JL, Mann DM, Wisnivesky JP, Home R, Leventhal H, Musumeci-Szabó TJ et al. Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the Medication Adherence Report Scale for Asthma. Ann Allergy Asthma Immunol 2009;103:325331.
  • 29
    Hahn SR, Park J, Skinner EP, Yu-Isenberg KS, Weaver MB, Crawford B et al. Development of the ASK-20 adherence barrier survey. Curr Med Res Opin 2008;24:21272138. Epub 2008 Jun 12.
  • 30
    Foster NE, Bishop A, Thomas E, Main C, Horne R, Weinman J et al. Illness perceptions of low back pain patients in primary care: what are they, do they change and are they associated with outcome? Pain 2008;136:177187.
  • 31
    Searle A, Norman P, Thompson R, Vedhara K. Illness representations among patients with type 2 diabetes and their partners: relationships with self-management behaviors. J Psychosom Res 2007;63:175184.
  • 32
    Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron LD, Buick D. The revised illness perception questionnaire (IPQ-R). Psychol Health 2002;17:116.
  • 33
    Lloyd A, McIntosh E, Rabe KF, Williams A. Patient preferences for asthma therapy: a discrete choice experiment. Prim Care Respir J 2007;16:241248.
  • 34
    Mahadevia P, Shah S, Mannix S, Brewster-Jordan J, Kleinman L, Liebman C et al. Willingness to pay for sensory attributes of intranasal corticosteroids among patients with allergic rhinitis. J Manag Care Pharm 2006;12:143151.
  • 35
    Keith PK, Haddon J, Birch S. A cost-benefit analysis using a willingness-to-pay questionnaire of intranasal budesonide for seasonal allergic rhinitis. Rhinocort Study Group. Ann Allergy Asthma Immunol 2000;84:5562.
  • 36
    Herman JM. The use of patients’ preferences in family practice. J Fam Pract 1985;20:153156.
  • 37
    Meltzer EO, Hadley J, Blaiss M, Benninger M, Kimel M, Kleinman L et al. Development of questionnaires to measure patient preferences for intranasal corticosteroids in patients with allergic rhinitis. Otolaryngol Head Neck Surg 2005;132:197207.
  • 38
    Ende J, Kazis L, Ash A, Moskowitz MA. Measuring patients’ desire for autonomy: decision making and information-seeking preferences among medical patients. J Gen Intern Med 1989;4:2330.
  • 39
    Goss CH, Quittner AL. Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc 2007;4:378386.
  • 40
    Wasserfallen JB, Gold K, Schulman KA, Baraniuk JN. Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials. J Allergy Clin Immunol 1997;100:1622.
  • 41
    Bousquet PJ, Combescure C, Klossek JM, Daurès JP, Bousquet J. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol 2009;123:13491354. Epub 2009 Apr 14.
  • 42
    Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Revised 2006. Available at: http://ginasthma.com
  • 43
    Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86): 8160.
  • 44
    Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ et al. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol 2009;124:428433. Epub 2009 Aug 5.
  • 45
    Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113:5965.
  • 46
    Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902907.
  • 47
    Control of Allergic Rhinitis and Asthma Test” (CARAT) project. http://carat.med.up.pt/
  • 48
    Nogueira-Silva L, Martins SV, Cruz-Correia R, Azevedo LF, Morais-Almeida M, Bugalho-Almeida A et al. Control of allergic rhinitis and asthma test--a formal approach to the development of a measuring tool. Respir Res 2009;17:10.
  • 49
    Bouwer WBF, Koopmanschap MA, Rutten FHH. Productivity costs measurement through quality of life? A response to the recommendation of the Washington panel Health Econ 1997;6:253259.
  • 50
    Andréasson E, Svensson K, Berggren F. The validity of the work productivity and activity impairment questionnaire for patients with asthma (WPAI-asthma): results from a webbased study. Value Health 2003;6:780.
  • 51
    Reilly MC, Tanner A, Meltzer EO. Work, classroom and activity impairment instruments: validation studies in allergic rhinitis. Clin Drug Invest 1996;11:278288.
  • 52
    Sifneos PE. Alexithymia: Past and present. Am J Psychiatry 1996;153:137142.
  • 53
    Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale–I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994;38:2332.
  • 54
    Bagby RM, Taylor GJ, Parker JD. The Twenty-item Toronto Alexithymia Scale–II. Convergent, discriminant, and concurrent validity. J Psychosom Res 1994;38:3340.
  • 55
    Folkman S, Lazarus RS, Gruen RJ, DeLongis A. Appraisal, coping, health status, and psychological symptoms. J Pers Soc Psychol 1986;50:571579.
  • 56
    Carver CS, Scheier MF, Weintraunb JK. Assessing coping strategies: a theoretically based approach. J Personality Social Psychol 1989;74:267283.
  • 57
    Petersen C, Schmidt S, Bullinger M. The DISABKIDS group: brief report: development and pilot testing of a coping questionnaire for children and adolescents with chronic health conditions. J Pediatr Psychol 2004;29:635640.
  • 58
    Rotter JB. Generalized expectancies for internal versus external control of reinforcement. Psychol Monogr 1966;80:128.
  • 59
    Wallston KA, Wallston BS. Who is responsible for your health? The construct of health locus of control. In SandersG, SulsJ, editors. Social Psychology and Health and Illness, Hillsdale, NJ: Erlbaum, 1982:6595.
  • 60
    Marsh HW, Richards GE. The Rotter Locus of Control Scale: the comparison of alternative response formats and implications for reliability, validity and dimensionality. J Res Pers 1986;20:509558.
  • 61
    Carver CS, Scheier MF. Perspectives on Personality, 4th edn. Boston: Allyn and Bacon, 2000.
  • 62
    Butcher JN, Dahlstrom WG, Graham JR, Tellegen A, Kaemmer B. The Minnesota Multiphasic Personality Inventory-2 (MMPI-2): manual for administration and scoring. Minneapolis, MN: University of Minnesota Press, 1989.
  • 63
    Oliver P. John and Sanjay Srivastava. The Big-Five Trait Taxonomy: history, Measurement, and Theoretical Perspectives. In: PervinLA, JohnOP, editors. Handbook of Personality: Theory and Research, 2nd edn. New York: Guilford Press, 1999:102139.
  • 64
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision: DSM-IV-TR. Washington, DC: American Psychiatric Publishing, Inc., 2000.
  • 65
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. “An inventory for measuring depression”. Arch Gen Psychiatry 1961; 4:561571.
  • 66
    Snaith RP, Zigmond AS. The Hospital Anxiety and Depression Scale. Br Med J (Clin Res Ed) 1986;292:344.
  • 67
    Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs AG. Manual for the State-Trait Anxiety Inventory (Form Y). Consulting Psychologists Press, Inc., Palo Alto, 1983.
  • 68
    Aldwin C. Stress, Coping, and Development, 2nd edn. New York: The Guilford Press, 2007.
  • 69
    McNair DM, Lorr M, Droppleman LF. POMS Manual: Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service, 1992.
  • 70
    Lavoie KL, Bouthillier D, Bacon SL, Lemière C, Martin J, Hamid Q et al. Psychological distress and maladaptive coping styles in patients with severe versus moderate asthma. Chest 2010;1:12.
  • 71
    Zielinski TA, Brown ES, Nejtek VA, Khan DA, Moore JJ, Rush AJ. Depression in Asthma: Prevalence and Clinical Implications. Prim Care Companion. J Clin Psychiatry 2000;2:153158.
  • 72
    Deshmukh VM, Toelle BG, Usherwood T, O’Grady B, Jenkins CR. The association of comorbid anxiety and depression with asthma-related quality of life and symptom perception in adults. Respirology 2008;13:695702.
  • 73
    Strine TW, Mokdad AH, Balluz LS, Berry JT, Gonzalez O. Impact of depression and anxiety on quality of life, health behaviors, and asthma control among adults in the United States with asthma, 2006. J Asthma 2008;45:123133.
  • 74
    Di Marco F, Verga M, Santus P, Giovannelli F, Busatto P, Neri M et al. Close correlation between anxiety, depression, and asthma control. Respir Med 2009;1:122.
  • 75
    Stull DE, Schaefer M, Crespi S, Sandor DW. Relative strength of relationships of nasal congestion and ocular symptoms with sleep, mood and productivity. Curr Med Res Opin 2009;25:17851792.
  • 76
    Stull DE, Roberts L, Frank L, Heithoff K. Relationship of nasal congestion with sleep, mood, and productivity. Curr Med Res Opin 2007;23:811819.
  • 77
    Hyland ME. The Living with Asthma Questionnaire. Respir Med 1991;85:3337.
  • 78
    Bayliss MS, Espindle DM, Buchner D, Blaiss MS, Ware JE. A new tool for monitoring asthma outcomes: the ITG Asthma Short Form. Qual Life Res 2000;9:451466.
  • 79
    Barley EA, Quirk FH, Jones PW. Asthma health status measurement in clinical practice: validity of a new short and simple instrument. Respir Med 1998;92:12071214.
  • 80
    Hyland ME, Ley A, Fisher DW, Woodward V. Measurement of psychological distress in asthma and asthma management programmes. Br J Clin Psychol 1995;34(pt4):601611.
  • 81
    Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:7683.
  • 82
    Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 1992;45:461472.
  • 83
    Zillich AJ, Blumenschein K, Johannesson M, Freeman P. Assessment of the relationship between measures of disease severity, quality of life, and willingness to pay in asthma. Pharmacoeconomics 2002;20:257265.
  • 84
    Mishoe SC, Baker RR, Poole S, Harrell LM, Arant CB, Rupp NT. Development of an instrument to assess stress levels and quality of life in children with asthma. J Asthma 1998;35:553563.
  • 85
    Christie MJ, French D, Sowden A, West A. Development of child-centered disease-specific questionnaires for living with asthma. Psychosom Med 1993;55:541548.
  • 86
    Sullivan SA, Olson LM. Developing condition-specific measures of functional status and well-being for children. Clin Perform Qual Health Care 1995;3:132138.
  • 87
    Le Coq EM, Colland VT, Boeke AJP, Bezemer DP, Van EIJKJTM. Reproducibility, construct validity, and responsiveness of the “How Are You?” (HAY), a self-report quality of life questionnaire for children with asthma. J Asthma 2000;37:4358.
  • 88
    Bukstein DA, McGrath MM, Buchnew DA, Landgraf J, Goss TF. Evaluation of a short form for measuring health-related quality of life among pediatric asthma patients. J Allergy Clin Immunol 2000; 105:245251.
  • 89
    Rutishauser C, Sawyer SM, Bond L, Coffey C, Bowes G. Development and validation of the Adolescent Asthma Quality of Life Questionnaire (AAQOL). Eur Respir J 2001;17:5258.
  • 90
    Creer Tl, Wigal JK, Kotses H, Hatala JC, McConnaughy K, Winder JA. A life activities questionnaire for children asthma. J Asthma 1993;30:467473.
  • 91
    Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in the parents of children with asthma. Qual Life Res 1996;5:2734.
  • 92
    Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res 1996;5:3546.
  • 93
    Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure health-related quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2003;111:484490.
  • 94
    Juniper EF, Howland WC, Roberts NB, Thompson AK, King DR. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998;101:2.
  • 95
    Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exper Allergy 1991;21:7783.
  • 96
    Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000; 30:132140.
  • 97
    Benninger MS, Senior BA. The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg 1997;123:11751179.
  • 98
    Piccirillo JF, Merritt MG Jr, Richards ML. Psychometric and clinimetric validity of the 20-Item SinoNasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg 2002;126:4147.
  • 99
    Anderson ER, Murphy MP, Weymuller EA Jr. Clinimetric evaluation of the Sinonasal Outcome Test-16. Otolaryngol Head Neck Surg 1999;121:702707.
  • 100
    Roberts G, Hurley C, Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multi-system allergic disease. J Allergy Clin Immunol 2003;111:491497.
  • 101
    Baiardini I, Braido F, Fassio O, Tarantini F, Pasquali M, Tarchino F et al. A new tool to assess and monitor the burden of chronic cough on quality of life: chronic Cough Impact Questionnaire. Allergy 2005;60:482488.
  • 102
    Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: leicester Cough Questionnaire (LCQ). Thorax 2003;58:339343.
  • 103
    French CT, Irwin RS, Fletcher KE, Adams TM. Evaluation of a cough-specific quality-of-life questionnaire. Chest 2002;121:11231131.
  • 104
    Maillé AR, Koning CJM, Zwinderman AH, Willems LN, Dijkman JH, Kaptein AA. The development of the ‘‘Quality-of-life for Respiratory Illness Questionnaire (QOLRIQ)’’: a disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung disease. Respir Med 1997;91:297309.
  • 105
    Jacobs JE, Maillé AR, Akkermans RP, Van Weel C, Grol RP. Assessing the quality of life of adults with chronic respiratory diseases in routine primary care: construction and first validation of the 10-Item Respiratory Illness Questionnaire-monitoring 10 (RIQ-MON10. Qual Life Res 2004;13:11171127.
  • 106
    Jones PW, Quirk FH, Baveystock CM. The St. George’s Respiratory Questionnaire. Resp Med 1991;85(suppl):2531.
  • 107
    Alexander M, Berger W, Buchholz P, Walt J, Burk C, Lee J et al. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ). Health Qual Life Outcomes 2005;3:67.
  • 108
    Sacchetti M, Baiardini I, Lambiase A, Aronni S, Fassio O, Gramiccioni C et al. Development and testing of the Quality of life in children with vernal keratoconjunctivitis questionnaire. Am J Ophthalmol 2007;144:557563.
  • 109
    Ried LD, Nau DP, Grainger-Rousseau TJ. Evaluation of patient’s Health-Related Quality of Life using a modified and shortened version of the Living With Asthma Questionnaire (ms-LWAQ) and the medical outcomes study, Short-Form 36 (SF-36). Qual Life Res 1999;8:491499.
  • 110
    Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999;14:328.
  • 111
    Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407e15.
  • 112
    Schunemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH. Measurement properties and interpretability of the chronic respiratory disease questionnaire (CRQ). COPD 2005;2(1):8189.
  • 113
    Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999;2:113127.
  • 114
    Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008;61:1029.
  • 115
    Barnes ML, Vaidyanathan S, Williamson PA, Lipworth BJ. The minimal clinically important difference in allergic rhinitis. Clin Exp Allergy 2010;40:242250.
  • 116
    Wood PR, Smith B, O’Donnell L, Galbreath AD, Lara M, Forkner E et al. Quantifying asthma symptoms in adults: the Lara Asthma Symptom Scale. J Allergy Clin Immunol 2007; 120:13681372.
  • 117
    LeBlanc A, Robichaud P, Lacasse Y, Boulet LP. Quantification of asthma control: validation of the Asthma Control Scoring System. Allergy 2007;62:120125.
  • 118
    Skinner EA, Diette GB, Algatt-Bergstrom PJ, Nguyen TT, Clark RD, Markson LE et al. The Asthma Therapy Assessment Questionnaire (ATAQ) for children and adolescents. Dis Manag 2004;7:305313.
  • 119
    Van Oene CM, Van Reij EJ, Sprangers MA, Fokkens WJ. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: a systematic review. Allergy 2007;62:13591371.